Loading…
ONC
BEONE MEDICINES LTD.NasdaqResearch view
Healthcare · Pharmaceutical Preparations · SEC EDGAR FY 2025-12-31
Price history
Interactive · live data via TradingView🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-12-31SectorHealthcare
Income$286.9M
Sales$5.3B
Book/sh$2.95
Cash/sh$3.12
Dividend TTM—
Payout—
Employees—
IPO—
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$1.2B
2021
$1.4B
2022
$2.5B
2023
$3.8B
2024
$5.3B
2025
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1.2B | $1.4B | $2.5B | $3.8B | $5.3B |
| Gross Profit | $1.0B | $1.1B | $2.1B | $3.2B | $4.7B |
| Operating Income | $-1.4B | $-1.8B | $-1.2B | $-568.2M | $447.1M |
| Net Income | $-1.5B | $-2.0B | $-881.7M | $-644.8M | $286.9M |
| Diluted EPS | $-1.21 | $-1.49 | $-0.65 | $-0.47 | $0.19 |
| Operating Cash Flow | $-1.3B | $-1.5B | $-1.2B | $-140.6M | $1.1B |
| Free Cash Flow | $-1.6B | $-1.8B | $-1.7B | $-633.3M | $941.7M |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
Follow the news. Follow the move.
ONC story timeline
Company updates and connected market context, with the dated price move attached.
1
Stories
1
Direct
COMMUNITY · $ONC0 theses
POST YOUR TAKE →Related Stocks
Loading peers…
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.